Loading clinical trials...
Loading clinical trials...
A Randomized, Open-Label, 3-Period Crossover Study to Evaluate the Effect of Multiple Doses of DVS SR and Paroxetine on the CYP2D6 Biotransformation of Codeine to Morphine in Healthy Subjects.
Conditions
Interventions
desvenlafaxine sustained release (DVS SR)
Paroxetine
+1 more
Start Date
January 1, 2007
Completion Date
March 1, 2007
Last Updated
December 28, 2007
NCT05901259
NCT03759522
NCT07425275
NCT07186751
NCT06574165
NCT06157866
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions